{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:54:10Z","timestamp":1784296450843,"version":"3.55.0"},"reference-count":329,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NCI","award":["CA185490"],"award-info":[{"award-number":["CA185490"]}]},{"name":"NIH\/NCI","award":["CA204801"],"award-info":[{"award-number":["CA204801"]}]},{"name":"NIH\/NCI","award":["HHSN261201600039C"],"award-info":[{"award-number":["HHSN261201600039C"]}]},{"name":"USAMCI"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.canlet.2017.05.011","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T22:32:39Z","timestamp":1495665159000},"page":"123-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["MicroRNAs in gynecological cancers: Small molecules with big implications"],"prefix":"10.1016","volume":"407","author":[{"given":"Sanjeev K.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haseeb","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlandric","family":"Miree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney P.","family":"Rocconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Scalici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-6330","authenticated-orcid":false,"given":"Ajay P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2017.05.011_bib1","first-page":"59","article-title":"Immunotherapy: new strategies for the treatment of gynecologic malignancies","volume":"30","author":"Bourla","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.canlet.2017.05.011_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2013.12.039","article-title":"Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology","volume":"133","author":"Collins","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2017.05.011_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-61779-427-8_21","article-title":"miRNAs in human cancer","volume":"822","author":"Zhong","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2017.05.011_bib5","first-page":"7","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.canlet.2017.05.011_bib6","first-page":"143","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review \u2013 past, present and future","volume":"7","author":"Dehal","year":"2016","journal-title":"J.\u00a0Gastrointest. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib7","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2017.05.011_bib8","doi-asserted-by":"crossref","first-page":"e5311","DOI":"10.1371\/journal.pone.0005311","article-title":"Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries","volume":"4","author":"Wyman","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib9","doi-asserted-by":"crossref","first-page":"e22508","DOI":"10.1371\/journal.pone.0022508","article-title":"Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach","volume":"6","author":"Shahab","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2016-203679","article-title":"Small RNA sequencing reveals a comprehensive miRNA signature of BRCA1-associated high-grade serous ovarian cancer","author":"Brouwer","year":"2016","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.canlet.2017.05.011_bib11","first-page":"258","article-title":"Comparative analysis of differentially expressed miRNAs and their downstream mRNAs in ovarian cancer and its associated endometriosis","volume":"7","author":"Wu","year":"2015","journal-title":"J.\u00a0Cancer Sci. Ther."},{"key":"10.1016\/j.canlet.2017.05.011_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2008.08.036","article-title":"The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform","volume":"112","author":"Resnick","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib13","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","article-title":"MicroRNA expression profiles in serous ovarian carcinoma","volume":"14","author":"Nam","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3892\/ijmm.2013.1424","article-title":"Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma","volume":"32","author":"Chen","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib15","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1158\/1078-0432.CCR-07-1231","article-title":"Altered MicroRNA expression in cervical carcinomas","volume":"14","author":"Lee","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib16","first-page":"2561","article-title":"Unique microRNA expression profiles in cervical cancer","volume":"33","author":"Gocze","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/onc.2012.20","article-title":"Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis","volume":"32","author":"Wilting","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.05.011_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/mco.2016.875","article-title":"Profiling analysis of circulating microRNA expression in cervical cancer","volume":"5","author":"Nagamitsu","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib19","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1007\/s13277-015-4248-7","article-title":"Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women","volume":"37","author":"Sharma","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3892\/mco.2015.560","article-title":"Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring","volume":"3","author":"Jia","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib21","first-page":"510","article-title":"Meta-analysis of microRNA expression profiling studies in human cervical cancer","volume":"32","author":"Li","year":"2015","journal-title":"Med. Oncol. (Northwood, Lond. Engl.)"},{"key":"10.1016\/j.canlet.2017.05.011_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/IGC.0000000000000913","article-title":"Aberrant MicroRNA expression in patients with endometrial cancer","volume":"27","author":"Montagnana","year":"2017","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.canlet.2017.05.011_bib23","first-page":"88","article-title":"[MicroRNA expression signature profile and its clinical significance in endometrioid carcinoma]","volume":"43","author":"Wang","year":"2014","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.canlet.2017.05.011_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12935-014-0088-6","article-title":"MicroRNA expression in human endometrial adenocarcinoma","volume":"14","author":"Jurcevic","year":"2014","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2017.05.011_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CEJ.0b013e328305a07a","article-title":"Expression profile of mammalian microRNAs in endometrioid adenocarcinoma","volume":"18","author":"Wu","year":"2009","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.canlet.2017.05.011_bib26","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/ijc.27840","article-title":"Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients","volume":"132","author":"Torres","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ygyno.2010.05.010","article-title":"MicroRNA signatures differentiate uterine cancer tumor subtypes","volume":"118","author":"Ratner","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib28","first-page":"391","article-title":"Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1\u20132 endometrial cancer","volume":"29","author":"Canlorbe","year":"2016","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol."},{"key":"10.1016\/j.canlet.2017.05.011_bib29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2012.05.022","article-title":"MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells","volume":"324","author":"Long","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2012.02.038","article-title":"MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5","volume":"322","author":"Xu","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib31","doi-asserted-by":"crossref","first-page":"e0120905","DOI":"10.1371\/journal.pone.0120905","article-title":"MiR-20a promotes cervical cancer proliferation and metastasis in\u00a0vitro and in\u00a0vivo","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canlet.2016.03.016","article-title":"B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells","volume":"375","author":"Sun","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2015.01.066","article-title":"miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7","volume":"458","author":"Zhou","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3727\/096504016X14732772150262","article-title":"MicroRNA-92a promotes cell proliferation in cervical cancer via inhibiting p21 expression and promoting cell cycle progression","volume":"25","author":"Su","year":"2017","journal-title":"Oncol. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib35","first-page":"10294","article-title":"Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1","volume":"8","author":"Xu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2017.05.011_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12867-015-0052-6","article-title":"microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4","volume":"16","author":"Li","year":"2015","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.canlet.2017.05.011_bib37","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1007\/s13277-014-2479-7","article-title":"Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1","volume":"35","author":"Lao","year":"2014","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.febslet.2013.11.019","article-title":"miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells","volume":"588","author":"Yang","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2013.09.142","article-title":"miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells","volume":"440","author":"Zhang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib40","doi-asserted-by":"crossref","first-page":"e46990","DOI":"10.1371\/journal.pone.0046990","article-title":"miR-205 expression promotes cell proliferation and migration of human cervical cancer cells","volume":"7","author":"Xie","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib41","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3892\/or.2015.3821","article-title":"MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN","volume":"33","author":"Yang","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib42","article-title":"MicroRNA-543 acts as a prognostic marker and promotes the cell proliferation in cervical cancer by BRCA1-interacting protein 1","volume":"39","author":"Dang","year":"2017","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/cbr.2016.1998","article-title":"miR-10b inhibits apoptosis and promotes proliferation and invasion of endometrial cancer cells via targeting HOXB3","volume":"31","author":"Chen","year":"2016","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.canlet.2017.05.011_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1476-4598-13-97","article-title":"microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway","volume":"13","author":"Mitamura","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000354462","article-title":"MicroRNA-182 promotes tumor cell growth by targeting transcription elongation factor A-like 7 in endometrial carcinoma","volume":"32","author":"Guo","year":"2013","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2017.05.011_bib46","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3892\/or.2016.4605","article-title":"Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182","volume":"35","author":"Devor","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib47","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/1471-2407-14-440","article-title":"MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib48","doi-asserted-by":"crossref","first-page":"e87563","DOI":"10.1371\/journal.pone.0087563","article-title":"Elevated MiR-222-3p promotes proliferation and invasion of endometrial carcinoma via targeting ERalpha","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib49","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.biopha.2017.01.117","article-title":"miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer","volume":"88","author":"He","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib50","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/abbs\/gmq026","article-title":"miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells","volume":"42","author":"Fan","year":"2010","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2017.05.011_bib51","first-page":"594","article-title":"MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer","volume":"27","author":"Zhang","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bbrc.2012.12.083","article-title":"mir-30d regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells","volume":"431","author":"Yang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib53","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.2147\/OTT.S90976","article-title":"MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12","volume":"9","author":"Liang","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2017.05.011_bib54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.lfs.2016.12.007","article-title":"MiR-376a promotion of proliferation and metastases in ovarian cancer: potential role as a biomarker","volume":"173","author":"Yang","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2017.05.011_bib55","doi-asserted-by":"crossref","first-page":"15180","DOI":"10.18632\/oncotarget.3737","article-title":"Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biopha.2015.12.005","article-title":"MiR-572 prompted cell proliferation of human ovarian cancer cells by suppressing PPP2R2C expression","volume":"77","author":"Wu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopha.2015.02.020","article-title":"MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression","volume":"71","author":"Ying","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib58","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.febslet.2013.05.054","article-title":"MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells","volume":"587","author":"Liu","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib59","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/iub.1051","article-title":"MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells","volume":"64","author":"Wei","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.canlet.2017.05.011_bib60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/dna.2015.3130","article-title":"microRNA-34a-upregulated retinoic acid-inducible gene-I promotes apoptosis and delays cell cycle transition in cervical cancer cells","volume":"35","author":"Wang","year":"2016","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.canlet.2017.05.011_bib61","doi-asserted-by":"crossref","first-page":"13155","DOI":"10.1007\/s13277-016-5261-1","article-title":"Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells","volume":"37","author":"Chandrasekaran","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib62","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.7314\/APJCP.2013.14.10.5915","article-title":"MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells","volume":"14","author":"Huang","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.canlet.2017.05.011_bib63","doi-asserted-by":"crossref","first-page":"e111860","DOI":"10.1371\/journal.pone.0111860","article-title":"miR-107 activates ATR\/Chk1 pathway and suppress cervical cancer invasion by targeting MCL1","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib64","doi-asserted-by":"crossref","first-page":"25266","DOI":"10.18632\/oncotarget.4457","article-title":"MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3","volume":"6","author":"Fan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib65","first-page":"71","article-title":"MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2","volume":"10","author":"Qin","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.canlet.2017.05.011_bib66","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1159\/000343320","article-title":"MiR-125b inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta","volume":"30","author":"Cui","year":"2012","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2017.05.011_bib67","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3892\/or.2015.4101","article-title":"miR-133a inhibits cervical cancer growth by targeting EGFR","volume":"34","author":"Song","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib68","first-page":"1109","article-title":"MicroRNA-138 inhibits proliferation of cervical cancer cells by targeting c-Met","volume":"20","author":"Li","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2017.05.011_bib69","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.3892\/ol.2016.5038","article-title":"MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer","volume":"12","author":"Zhou","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib70","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1007\/s13277-015-3483-2","article-title":"MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7","volume":"36","author":"Deng","year":"2015","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib71","first-page":"753","article-title":"miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2","volume":"5","author":"Liu","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib72","doi-asserted-by":"crossref","DOI":"10.3727\/096504017X14867268787969","article-title":"MiR-181a inhibits cervical cancer development via downregulating GRP78","author":"Luo","year":"2017","journal-title":"Oncol. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib73","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1007\/s13277-015-4292-3","article-title":"MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib74","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.3892\/ol.2015.3541","article-title":"microRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression","volume":"10","author":"Du","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib75","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1007\/s13277-015-4540-6","article-title":"MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000350125","article-title":"miR-203 suppresses tumor growth and angiogenesis by targeting VEGFA in cervical cancer","volume":"32","author":"Zhu","year":"2013","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2017.05.011_bib77","doi-asserted-by":"crossref","first-page":"14301","DOI":"10.1074\/jbc.M111.337642","article-title":"MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7","volume":"287","author":"Peng","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.05.011_bib78","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.febslet.2012.02.050","article-title":"MicroRNA-223 regulates FOXO1 expression and cell proliferation","volume":"586","author":"Wu","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbrc.2016.05.066","article-title":"microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2","volume":"475","author":"Wang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17081351","article-title":"MicroRNA-331-3p suppresses cervical cancer cell proliferation and E6\/E7 expression by targeting NRP2","volume":"17","author":"Fujii","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2017.05.011_bib81","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1016\/j.febslet.2014.07.020","article-title":"miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer","volume":"588","author":"Li","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib82","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3892\/or.2016.5242","article-title":"MicroRNA-362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1","volume":"37","author":"Shi","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib83","doi-asserted-by":"crossref","first-page":"25556","DOI":"10.1074\/jbc.M111.221564","article-title":"MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis","volume":"286","author":"Tian","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.05.011_bib84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/iep.12177","article-title":"miR-376c inhibits cervical cancer cell proliferation and invasion by targeting BMI1","volume":"97","author":"Deng","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.canlet.2017.05.011_bib85","doi-asserted-by":"crossref","DOI":"10.4238\/gmr15048853","article-title":"microRNA 421 induces apoptosis of c-33a cervical cancer cells via down-regulation of Bcl-xL","volume":"15","author":"Lai","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.biopha.2016.02.019","article-title":"MiR-486-3p targeting ECM1 represses cell proliferation and metastasis in cervical cancer","volume":"80","author":"Ye","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib87","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3109\/21691401.2015.1080171","article-title":"MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells","volume":"44","author":"Cong","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.canlet.2017.05.011_bib88","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.biopha.2016.04.023","article-title":"MicroRNA-744 inhibited cervical cancer growth and progression through apoptosis induction by regulating Bcl-2","volume":"81","author":"Chen","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib89","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.febslet.2013.05.065","article-title":"Let7a inhibits the growth of endometrial carcinoma cells by targeting aurora-B","volume":"587","author":"Liu","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib90","doi-asserted-by":"crossref","first-page":"E395","DOI":"10.1002\/ijc.27345","article-title":"MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma","volume":"131","author":"Hiroki","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib91","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.18632\/oncotarget.2157","article-title":"MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells","volume":"5","author":"Konno","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib92","first-page":"r149","article-title":"MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2","volume":"18","author":"Shang","year":"2012","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib93","first-page":"1540","article-title":"MicroRNA-340 inhibits tumor cell proliferation and induces apoptosis in endometrial carcinoma cell line RL 95-2","volume":"22","author":"Xie","year":"2016","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib94","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.18632\/oncotarget.6544","article-title":"MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC)","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib95","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3892\/or.2014.3303","article-title":"MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A","volume":"32","author":"Ye","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib96","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.18632\/oncotarget.7061","article-title":"The correlation between microRNA490-3p and TGFalpha in endometrial carcinoma tumorigenesis and progression","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib97","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13277-015-3686-6","article-title":"MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer","volume":"37","author":"Xu","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib98","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.febslet.2014.02.055","article-title":"MicroRNA-23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt-related transcription factor-2","volume":"588","author":"Li","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13046-016-0307-1","article-title":"MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression","volume":"35","author":"Yan","year":"2016","journal-title":"J.\u00a0Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.canlet.2017.05.011_bib100","doi-asserted-by":"crossref","first-page":"23793","DOI":"10.18632\/oncotarget.4363","article-title":"MiR-26b\/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib101","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.biopha.2013.12.001","article-title":"miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells","volume":"68","author":"Jiang","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib102","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s11095-011-0547-x","article-title":"MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf(1)\/cip(1))","volume":"28","author":"Semaan","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib103","first-page":"20263","article-title":"miRNA-101 inhibits ovarian cancer cells proliferation and invasion by down-regulating expression of SOCS-2","volume":"8","author":"Zheng","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib104","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.biopha.2015.12.027","article-title":"MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression","volume":"80","author":"Yang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib105","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/ijc.25575","article-title":"MiR-125b targets BCL3 and suppresses ovarian cancer proliferation","volume":"128","author":"Guan","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib106","doi-asserted-by":"crossref","first-page":"8726","DOI":"10.18632\/oncotarget.6474","article-title":"MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib107","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3892\/or.2016.5055","article-title":"MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene","volume":"36","author":"Bi","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib108","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.18632\/oncotarget.3254","article-title":"A\u00a0novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ","volume":"6","author":"Tan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib109","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s13277-013-1215-z","article-title":"miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor","volume":"35","author":"Guo","year":"2014","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib110","first-page":"10605","article-title":"MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1\/2 inactivation by targeting epidermal growth factor receptor","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2017.05.011_bib111","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cellsig.2014.03.002","article-title":"MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression","volume":"26","author":"Tang","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2017.05.011_bib112","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbrc.2013.10.052","article-title":"miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1","volume":"441","author":"Guo","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib113","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3892\/mmr.2015.3756","article-title":"MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in\u00a0vitro and in\u00a0vivo","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib114","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/bjc.2016.379","article-title":"microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP","volume":"116","author":"Li","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biopha.2015.07.035","article-title":"miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA","volume":"75","author":"Lan","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib116","first-page":"2716","article-title":"MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer","volume":"8","author":"Wang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib117","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/nar\/gkr730","article-title":"MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis","volume":"40","author":"Xu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib118","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bbrc.2013.10.053","article-title":"MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1","volume":"441","author":"Wu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib119","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2015.10.008","article-title":"MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer","volume":"139","author":"Chen","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3727\/096504016X14562725373798","article-title":"miR-146a inhibits proliferation and enhances chemosensitivity in epithelial ovarian cancer via reduction of SOD2","volume":"23","author":"Cui","year":"2016","journal-title":"Oncol. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib121","first-page":"447","article-title":"Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation","volume":"27","author":"Zhou","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib122","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.3892\/mmr.2015.3826","article-title":"MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3","volume":"12","author":"Zhao","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib123","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3727\/096504016X14685034103275","article-title":"Suppressive role of microRNA-148a in cell proliferation and invasion in ovarian cancer through targeting transforming growth factor-beta-induced 2","volume":"24","author":"Zhao","year":"2016","journal-title":"Oncol. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib124","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1038\/onc.2010.233","article-title":"MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers","volume":"29","author":"Imam","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.05.011_bib125","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3892\/ijo.2013.1896","article-title":"Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells","volume":"42","author":"Nakano","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib126","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13048-015-0186-7","article-title":"MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer","volume":"8","author":"Ibrahim","year":"2015","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib127","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3892\/mmr.2014.2021","article-title":"microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor alpha-positive ovarian cancer cells","volume":"9","author":"Li","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-015-0322-4","article-title":"miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting cyclin D1 and CDK6","volume":"14","author":"Xia","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib129","article-title":"MiR-221-3p targets ARF4 and inhibits the proliferation and migration of epithelial ovarian cancer cells","author":"Wu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib130","first-page":"4869","article-title":"MiR-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1","volume":"8","author":"Guo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2017.05.011_bib131","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1159\/000369664","article-title":"MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1","volume":"34","author":"Ge","year":"2014","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2017.05.011_bib132","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3892\/ijo.2015.2929","article-title":"miR3383p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2","volume":"46","author":"Wen","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib133","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3892\/ijo.2015.3114","article-title":"MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4","volume":"47","author":"Jin","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib134","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.biopha.2016.07.038","article-title":"Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene","volume":"83","author":"Liu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib135","doi-asserted-by":"crossref","DOI":"10.4149\/neo_2017_211","article-title":"miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA","volume":"64","author":"Han","year":"2017","journal-title":"Neoplasma"},{"key":"10.1016\/j.canlet.2017.05.011_bib136","first-page":"903","article-title":"miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12","volume":"17","author":"Lv","year":"2015","journal-title":"Clin. Transl. Oncol. Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mexico"},{"key":"10.1016\/j.canlet.2017.05.011_bib137","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2015.03.029","article-title":"MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression","volume":"362","author":"Chen","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib138","first-page":"617","article-title":"MiR-494 inhibits epithelial ovarian cancer growth by targeting c-Myc","volume":"22","author":"Yuan","year":"2016","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib139","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.3892\/ol.2016.4527","article-title":"miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2","volume":"11","author":"Zhao","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib140","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3892\/or.2016.5012","article-title":"Overexpression of microRNA-497 suppresses cell proliferation and induces apoptosis through targeting paired box 2 in human ovarian cancer","volume":"36","author":"Lin","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib141","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2015.04.005","article-title":"MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells","volume":"72","author":"Liu","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib142","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/path.4348","article-title":"MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4\/6-FOXM1 axis in ovarian cancer","volume":"233","author":"Liu","year":"2014","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.canlet.2017.05.011_bib143","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/OTT.S60289","article-title":"MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in\u00a0vitro by targeting XIAP","volume":"7","author":"Pang","year":"2014","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2017.05.011_bib144","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1007\/s13277-015-4377-z","article-title":"miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma","volume":"37","author":"Shi","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib145","first-page":"4855","article-title":"Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis","volume":"54","author":"Greenblatt","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib146","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1158\/0008-5472.CAN-07-1585","article-title":"MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth","volume":"67","author":"Corney","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib147","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/0008-5472.CAN-09-3875","article-title":"Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers","volume":"70","author":"Creighton","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib148","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1007\/s13277-015-3445-8","article-title":"MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL","volume":"36","author":"Li","year":"2015","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib149","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2017.05.011_bib150","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3892\/or.2015.3931","article-title":"Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN","volume":"33","author":"Xu","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib151","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-016-2231-3","article-title":"Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells","volume":"16","author":"Peralta-Zaragoza","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib152","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.abb.2016.03.019","article-title":"Nuclear factor-kappaB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog","volume":"598","author":"Feng","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.canlet.2017.05.011_bib153","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.25011\/cim.v37i3.21380","article-title":"MicroRNA-222 promotes the proliferation and migration of cervical cancer cells","volume":"37","author":"Sun","year":"2014","journal-title":"Clin. Invest. Med. Med. Clin. Exp."},{"key":"10.1016\/j.canlet.2017.05.011_bib154","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11033-014-3045-5","article-title":"MiR-200a is involved in proliferation and apoptosis in the human endometrial adenocarcinoma cell line HEC-1B by targeting the tumor suppressor PTEN","volume":"41","author":"Li","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib155","first-page":"1401","article-title":"miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma","volume":"35","author":"Yoneyama","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib156","first-page":"2433","article-title":"Long non-coding RNA derived miR-205-5p modulates human endometrial cancer by targeting PTEN","volume":"7","author":"Xin","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib157","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/ijmm_00000530","article-title":"MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein","volume":"26","author":"Lou","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib158","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3892\/or.2016.5010","article-title":"MicroRNA-106a regulates phosphatase and tensin homologue expression and promotes the proliferation and invasion of ovarian cancer cells","volume":"36","author":"Chen","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib159","doi-asserted-by":"crossref","first-page":"41330","DOI":"10.1038\/srep41330","article-title":"Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib161","doi-asserted-by":"crossref","first-page":"8766","DOI":"10.4238\/2015.July.31.25","article-title":"Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma","volume":"14","author":"Zou","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib162","doi-asserted-by":"crossref","first-page":"E281","DOI":"10.25011\/cim.v34i5.15671","article-title":"miR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells","volume":"34","author":"Lou","year":"2011","journal-title":"Clin. Invest. Med. Med. Clin. Exp."},{"key":"10.1016\/j.canlet.2017.05.011_bib163","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2009.08.044","article-title":"MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells","volume":"388","author":"Yao","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib164","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1111\/j.1742-4658.2009.07237.x","article-title":"MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1","volume":"276","author":"Guo","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2017.05.011_bib165","doi-asserted-by":"crossref","first-page":"24853","DOI":"10.18632\/oncotarget.15267","article-title":"NF-kappaB1, c-Rel, and ELK1 inhibit miR-134 expression leading to TAB1 upregulation in paclitaxel-resistant human ovarian cancer","volume":"8","author":"Shuang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib166","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/1873-3468.12502","article-title":"miR-429 is involved in regulation of NF-kappaBactivity by targeting IKKbeta and suppresses oncogenic activity in cervical cancer cells","volume":"591","author":"Fan","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib167","doi-asserted-by":"crossref","first-page":"e1445","DOI":"10.1038\/cddis.2014.389","article-title":"miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation","volume":"5","author":"Denoyelle","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2017.05.011_bib168","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-09-2552","article-title":"MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer","volume":"69","author":"Bhattacharya","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib169","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/534176a","article-title":"Cancer therapy: defining stemness","volume":"534","author":"Clevers","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2017.05.011_bib170","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/0008-5472.CAN-16-1115","article-title":"The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib171","doi-asserted-by":"crossref","first-page":"28882","DOI":"10.18632\/oncotarget.4921","article-title":"MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt\/beta-catenin signaling pathway","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib172","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-016-0415-y","article-title":"MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells","volume":"35","author":"Dong","year":"2016","journal-title":"J.\u00a0Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.canlet.2017.05.011_bib173","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2011.03.026","article-title":"MicroRNA-200a inhibits CD133\/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2","volume":"122","author":"Wu","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib174","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1757-2215-6-50","article-title":"MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial\u2013mesenchymal transition","volume":"6","author":"Chen","year":"2013","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib175","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1007\/s13277-014-1950-9","article-title":"EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway","volume":"35","author":"Liu","year":"2014","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib176","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.gene.2016.12.030","article-title":"MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A","volume":"605","author":"Chang","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2017.05.011_bib177","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.febslet.2014.12.002","article-title":"MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins","volume":"589","author":"Gao","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib178","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2016.11.017","article-title":"MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3","volume":"386","author":"Jeong","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib179","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1158\/1541-7786.MCR-13-0131","article-title":"miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma","volume":"11","author":"Liu","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib180","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3892\/ol.2015.4001","article-title":"MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1","volume":"11","author":"Zhao","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib181","doi-asserted-by":"crossref","first-page":"462","DOI":"10.18632\/oncotarget.1552","article-title":"Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma","volume":"5","author":"Schirmer","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib182","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/carcin\/bgq066","article-title":"MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells","volume":"31","author":"Pang","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2017.05.011_bib183","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3892\/ijo.2013.1851","article-title":"Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma","volume":"42","author":"Yamamoto","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib184","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.18632\/oncotarget.2836","article-title":"The microRNA-218\u223cSurvivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer","volume":"6","author":"Kogo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib185","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2016.02.006","article-title":"MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer","volume":"141","author":"Fan","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib186","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.ajpath.2011.07.037","article-title":"miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1","volume":"179","author":"Wang","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2017.05.011_bib187","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.3892\/or.2013.2400","article-title":"miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma","volume":"29","author":"Su","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib188","doi-asserted-by":"crossref","first-page":"30342","DOI":"10.1074\/jbc.M115.691857","article-title":"miR-346 up-regulates argonaute 2 (AGO2) protein expression to augment the activity of other MicroRNAs (miRNAs) and contributes to cervical cancer cell malignancy","volume":"290","author":"Guo","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.05.011_bib189","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40709-015-0035-2","article-title":"MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling","volume":"22","author":"Fang","year":"2015","journal-title":"J.\u00a0Biol. Res. (Thessalonike, Greece)"},{"key":"10.1016\/j.canlet.2017.05.011_bib190","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/jcb.24488","article-title":"MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas","volume":"114","author":"Wang","year":"2013","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.canlet.2017.05.011_bib191","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1757-2215-6-84","article-title":"MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1","volume":"6","author":"Zhang","year":"2013","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib192","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3892\/or.2013.2482","article-title":"miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w","volume":"30","author":"Cao","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib193","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1007\/s13277-015-4390-2","article-title":"miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6","volume":"37","author":"Shan","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib194","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gene.2016.04.001","article-title":"MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer","volume":"586","author":"Paudel","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2017.05.011_bib195","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbrc.2014.04.027","article-title":"MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2","volume":"447","author":"Xia","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib196","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1158\/1535-7163.MCT-13-0982","article-title":"Anti-miR182 reduces ovarian cancer burden, invasion, and metastasis: an in\u00a0vivo study in orthotopic xenografts of nude mice","volume":"13","author":"Xu","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2017.05.011_bib197","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2010.08.034","article-title":"An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer","volume":"119","author":"Li","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib198","doi-asserted-by":"crossref","first-page":"e52397","DOI":"10.1371\/journal.pone.0052397","article-title":"Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT\/mTOR\/Rac1 signaling and actin reorganization","volume":"7","author":"Imam","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib199","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ijc.28086","article-title":"MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1alpha","volume":"133","author":"Yeh","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib200","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1073\/pnas.1317242111","article-title":"Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis","volume":"111","author":"Joshi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2017.05.011_bib201","doi-asserted-by":"crossref","first-page":"12291","DOI":"10.18632\/oncotarget.2577","article-title":"MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer","volume":"5","author":"Zhang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib202","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1158\/0008-5472.CAN-10-0965","article-title":"Phosphoglucose isomerase\/autocrine motility factor mediates epithelial\u2013mesenchymal transition regulated by miR-200 in breast cancer cells","volume":"71","author":"Ahmad","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib203","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2017.05.011_bib204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2009.08.009","article-title":"Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition","volume":"116","author":"Bendoraite","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib205","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3892\/mmr.2016.4911","article-title":"MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial\u2013mesenchymal transition in cervical carcinoma","volume":"13","author":"Cheng","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib206","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.3892\/mmr.2016.4933","article-title":"MicroRNA-200b inhibits epithelial\u2013mesenchymal transition and migration of cervical cancer cells by directly targeting RhoE","volume":"13","author":"Cheng","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib207","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2010.12.339","article-title":"Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells","volume":"121","author":"Chen","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib208","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3892\/ijo.2015.3241","article-title":"miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer","volume":"48","author":"Tan","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib209","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/bjc.2016.244","article-title":"miR-23a promotes IKKalpha expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells","volume":"115","author":"Yang","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib210","first-page":"11224","article-title":"MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial\u2013mesenchymal transition","volume":"8","author":"Tang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2017.05.011_bib211","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1476-4598-10-99","article-title":"MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1","volume":"10","author":"Dong","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib212","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s12032-013-0484-0","article-title":"miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer","volume":"30","author":"Li","year":"2013","journal-title":"Med. Oncol. (Northwood, Lond. Engl.)"},{"key":"10.1016\/j.canlet.2017.05.011_bib213","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mc.21983","article-title":"MicroRNA-106b modulates epithelial\u2013mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines","volume":"53","author":"Dong","year":"2014","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2017.05.011_bib214","first-page":"1056","article-title":"Regulation of epithelial\u2013mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs","volume":"18","author":"Kent","year":"2016","journal-title":"Clin. Transl. Oncol. Off. Publ. Fed. Spanish Oncol. Soc. Natl. Cancer Inst. Mexico"},{"key":"10.1016\/j.canlet.2017.05.011_bib215","doi-asserted-by":"crossref","first-page":"20260","DOI":"10.18632\/oncotarget.7754","article-title":"Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression","volume":"7","author":"Dong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib216","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/jog.12756","article-title":"miR-205 promotes epithelial\u2013mesenchymal transition by targeting AKT signaling in endometrial cancer cells","volume":"41","author":"Jin","year":"2015","journal-title":"J.\u00a0Obstet. Gynaecol. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib217","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3892\/or.2015.4500","article-title":"miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial\u2013mesenchymal transition","volume":"35","author":"Yao","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib218","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopha.2016.03.035","article-title":"The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL","volume":"80","author":"Wang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2017.05.011_bib219","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3892\/or.2016.5025","article-title":"MicroRNA-124 inhibits proliferation, invasion, migration and epithelial\u2013mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib220","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbrc.2016.12.020","article-title":"MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4","volume":"485","author":"Xu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib221","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/ncomms3977","article-title":"microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial\u2013mesenchymal transition","volume":"5","author":"Parikh","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib222","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12935-016-0298-1","article-title":"MiR-519d facilitates the progression and metastasis of cervical cancer through direct targeting Smad7","volume":"16","author":"Zhou","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2017.05.011_bib223","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.3892\/or.2016.5160","article-title":"Let7a suppresses cell proliferation via the TGFbeta\/SMAD signaling pathway in cervical cancer","volume":"36","author":"Wu","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib224","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12935-016-0342-1","article-title":"MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3","volume":"16","author":"Liu","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2017.05.011_bib225","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1159\/000358647","article-title":"Id-1, a protein repressed by miR-29b, facilitates the TGFbeta1-induced epithelial\u2013mesenchymal transition in human ovarian cancer cells","volume":"33","author":"Teng","year":"2014","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2017.05.011_bib226","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/IGC.0000000000000546","article-title":"miR-30d blocked transforming growth factor beta1-induced epithelial\u2013mesenchymal transition by targeting snail in ovarian cancer cells","volume":"25","author":"Ye","year":"2015","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.canlet.2017.05.011_bib227","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejca.2015.12.016","article-title":"Targeting the tumour microenvironment in ovarian cancer","volume":"56","author":"Hansen","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib228","first-page":"139","article-title":"Future directions in the field of endometrial cancer research: the need to investigate the tumor microenvironment","volume":"31","author":"Felix","year":"2010","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib229","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1038\/onc.2012.351","article-title":"Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility","volume":"32","author":"Aprelikova","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.05.011_bib230","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/156800908785699324","article-title":"Importance of Wnt signaling in the tumor stroma microenvironment","volume":"8","author":"Macheda","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.canlet.2017.05.011_bib231","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2159-8290.CD-12-0206","article-title":"MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer","volume":"2","author":"Mitra","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2017.05.011_bib232","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ncb3330","article-title":"The ever-expanding role of HIF in tumour and stromal biology","volume":"18","author":"LaGory","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2017.05.011_bib233","doi-asserted-by":"crossref","first-page":"11342","DOI":"10.18632\/oncotarget.3604","article-title":"The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma","volume":"6","author":"Kinose","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib234","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1038\/onc.2015.43","article-title":"Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis","volume":"34","author":"Mitra","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.05.011_bib235","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ctrv.2007.10.005","article-title":"Evolving role of uPA\/uPAR system in human cancers","volume":"34","author":"Dass","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canlet.2017.05.011_bib236","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/onc.2014.9","article-title":"miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer","volume":"34","author":"Wen","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.05.011_bib237","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12943-016-0509-3","article-title":"Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment","volume":"15","author":"Hanna","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib238","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1158\/1541-7786.MCR-11-0245","article-title":"MicroRNA-30c-2\u2217 expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9","volume":"9","author":"Jia","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib239","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4161\/onci.20020","article-title":"Good things come in small packages: therapeutic anti-tumor immunity induced by microRNA nanoparticles","volume":"1","author":"Cubillos-Ruiz","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2017.05.011_bib240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-016-0301-4","article-title":"MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression","volume":"10","author":"Chen","year":"2017","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib241","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1389450114666140106100909","article-title":"Therapeutic targeting of cancers with loss of PTEN function","volume":"15","author":"Dillon","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.canlet.2017.05.011_bib242","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.febslet.2012.03.006","article-title":"Involvement of microRNA-93, a new regulator of PTEN\/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells","volume":"586","author":"Fu","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib243","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3892\/or.2012.1823","article-title":"Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1\/P-glycoprotein-mediated drug resistance","volume":"28","author":"Yang","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib244","doi-asserted-by":"crossref","first-page":"e0128886","DOI":"10.1371\/journal.pone.0128886","article-title":"MiR-130a and MiR-374a function as novel regulators of cisplatin resistance in human ovarian cancer A2780 cells","volume":"10","author":"Li","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib245","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3892\/mmr.2015.4556","article-title":"NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib246","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/onc.2015.84","article-title":"miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin","volume":"35","author":"Zhu","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.05.011_bib247","doi-asserted-by":"crossref","first-page":"e52310","DOI":"10.1371\/journal.pone.0052310","article-title":"Up-regulated miR155 reverses the epithelial\u2013mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells","volume":"7","author":"Lei","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib248","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/ERC-10-0148","article-title":"The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients","volume":"18","author":"Leskela","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib249","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.molonc.2015.04.015","article-title":"The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells","volume":"9","author":"Brozovic","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib250","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1158\/1535-7163.MCT-12-0463","article-title":"Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel","volume":"11","author":"Cittelly","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2017.05.011_bib251","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygyno.2011.04.033","article-title":"MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management","volume":"122","author":"Lu","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib252","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/07357907.2012.707265","article-title":"Reversal of paclitaxel resistance in epithelial ovarian carcinoma cells by a MUC1 aptamer-let-7i chimera","volume":"30","author":"Liu","year":"2012","journal-title":"Cancer Invest."},{"key":"10.1016\/j.canlet.2017.05.011_bib253","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv108","article-title":"Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers","volume":"107","author":"Liu","year":"2015","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2017.05.011_bib254","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cas.13104","article-title":"miR-25-3p reverses epithelial\u2013mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells","volume":"108","author":"Song","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2017.05.011_bib255","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1038\/oncsis.2013.3","article-title":"Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET","volume":"2","author":"Mitamura","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2017.05.011_bib256","doi-asserted-by":"crossref","first-page":"294","DOI":"10.18632\/oncoscience.143","article-title":"P18\/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane","volume":"2","author":"Hassan","year":"2015","journal-title":"Oncoscience"},{"key":"10.1016\/j.canlet.2017.05.011_bib257","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1471-2407-13-216","article-title":"MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples","volume":"13","author":"Li","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib258","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1038\/oncsis.2013.39","article-title":"Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin","volume":"2","author":"Cai","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2017.05.011_bib259","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ijc.28399","article-title":"Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells","volume":"134","author":"Yu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib260","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/IGC.0000000000000252","article-title":"Deregulation of miR-128 in ovarian cancer promotes cisplatin resistance","volume":"24","author":"Li","year":"2014","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.canlet.2017.05.011_bib261","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3892\/or.2014.3640","article-title":"Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer","volume":"33","author":"Zhao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib262","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1007\/s13277-016-4804-9","article-title":"MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells","volume":"37","author":"Chen","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib263","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3892\/ol.2013.1448","article-title":"microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin","volume":"6","author":"Wang","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib264","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/cgt.2017.6","article-title":"MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1","volume":"24","author":"Liu","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2017.05.011_bib265","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1007\/s13277-014-2551-3","article-title":"MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells","volume":"35","author":"Zhou","year":"2014","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib266","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/CAD.0000000000000107","article-title":"MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3","volume":"25","author":"Wu","year":"2014","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canlet.2017.05.011_bib267","doi-asserted-by":"crossref","first-page":"87091","DOI":"10.18632\/oncotarget.13526","article-title":"MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1","volume":"7","author":"Tian","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib268","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12943-015-0464-4","article-title":"miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway","volume":"14","author":"van Jaarsveld","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib269","doi-asserted-by":"crossref","first-page":"53254","DOI":"10.18632\/oncotarget.10736","article-title":"MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib270","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.3390\/ijms131216053","article-title":"MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer","volume":"13","author":"Li","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2017.05.011_bib271","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.3892\/mmr.2014.2622","article-title":"Restoration of microRNA218 increases cellular chemosensitivity to cervical cancer by inhibiting cellcycle progression","volume":"10","author":"Dong","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib272","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ygyno.2014.01.034","article-title":"The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer","volume":"132","author":"Chan","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib273","doi-asserted-by":"crossref","first-page":"e97094","DOI":"10.1371\/journal.pone.0097094","article-title":"Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1\/c-Jun pathway","volume":"9","author":"Echevarria-Vargas","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib274","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11596-011-0487-z","article-title":"miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1","volume":"31","author":"Kong","year":"2011","journal-title":"J.\u00a0Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.canlet.2017.05.011_bib275","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3892\/or.2014.3311","article-title":"Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma","volume":"32","author":"Zhao","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib276","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1242\/jcs.072223","article-title":"MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance","volume":"124","author":"Ye","year":"2011","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.canlet.2017.05.011_bib277","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/pgs.15.166","article-title":"MicroRNA-509-3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis","volume":"17","author":"Chen","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.canlet.2017.05.011_bib278","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bjc.2013.305","article-title":"Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer","volume":"109","author":"Huh","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib279","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3892\/ol.2013.1644","article-title":"microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells","volume":"7","author":"Li","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib280","doi-asserted-by":"crossref","first-page":"12151","DOI":"10.1007\/s13277-014-2520-x","article-title":"MicroRNA 130b enhances drug resistance in human ovarian cancer cells","volume":"35","author":"Zong","year":"2014","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib281","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1016\/j.febslet.2015.08.047","article-title":"Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells","volume":"589","author":"Shuang","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib282","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ijc.28774","article-title":"miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6","volume":"135","author":"Zhu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib283","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13048-015-0178-7","article-title":"MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88","volume":"8","author":"Zhan","year":"2015","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib284","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13048-015-0207-6","article-title":"MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1","volume":"8","author":"Sun","year":"2015","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib285","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1007\/s13277-015-3365-7","article-title":"MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK","volume":"36","author":"Zou","year":"2015","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib286","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2014.04.055","article-title":"Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells","volume":"134","author":"Wang","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib287","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/cam4.409","article-title":"Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells","volume":"4","author":"Weiner-Gorzel","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib288","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13048-014-0084-4","article-title":"microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells","volume":"7","author":"Chen","year":"2014","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib289","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1038\/oncsis.2016.1","article-title":"MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression","volume":"5","author":"Fan","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2017.05.011_bib290","first-page":"432","article-title":"Upregulation of microRNA-224 sensitizes human cervical cells SiHa to paclitaxel","volume":"36","author":"Lin","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib291","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/bjc.2013.308","article-title":"miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer","volume":"109","author":"Shen","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib292","doi-asserted-by":"crossref","first-page":"e109299","DOI":"10.1371\/journal.pone.0109299","article-title":"miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib293","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s13277-015-4081-z","article-title":"Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells","volume":"37","author":"Samuel","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevel. Biol. Med."},{"key":"10.1016\/j.canlet.2017.05.011_bib294","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jcla.20340","article-title":"The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass","volume":"23","author":"Montagnana","year":"2009","journal-title":"J.\u00a0Clin. Lab. Anal."},{"key":"10.1016\/j.canlet.2017.05.011_bib295","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1477-7819-12-169","article-title":"Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis","volume":"12","author":"Bie","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib296","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2006.09.028","article-title":"CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From the Danish \u201cMALOVA\u201d Ovarian Cancer Study","volume":"104","author":"Hogdall","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib297","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1155\/2007\/309382","article-title":"Early detection of ovarian cancer","volume":"23","author":"Badgwell","year":"2007","journal-title":"Dis. Markers"},{"key":"10.1016\/j.canlet.2017.05.011_bib298","first-page":"1239","article-title":"Value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes","volume":"8","author":"Liu","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2017.05.011_bib299","first-page":"779","article-title":"Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features","volume":"17","author":"Zuberi","year":"2015","journal-title":"Clin. Transl. Oncol. Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mexico"},{"key":"10.1016\/j.canlet.2017.05.011_bib300","doi-asserted-by":"crossref","first-page":"e77853","DOI":"10.1371\/journal.pone.0077853","article-title":"Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib301","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1158\/1078-0432.CCR-13-0360","article-title":"MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities","volume":"19","author":"Calura","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib302","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3892\/ol.2013.1338","article-title":"Identification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancer","volume":"6","author":"Jia","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib303","first-page":"3939","article-title":"Expression profile of MicroRNA-203 and its DeltaNp63 target in cervical carcinogenesis: prospects for cervical cancer screening","volume":"36","author":"Coimbra","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib304","doi-asserted-by":"crossref","first-page":"17995","DOI":"10.4238\/2015.December.22.25","article-title":"Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer","volume":"14","author":"Liu","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib305","doi-asserted-by":"crossref","DOI":"10.1186\/2050-7771-1-12","article-title":"Prognostic significance of miR-194 in endometrial cancer","volume":"1","author":"Zhai","year":"2013","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib306","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.surg.2012.12.004","article-title":"MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor","volume":"153","author":"Luo","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.canlet.2017.05.011_bib307","first-page":"1103","article-title":"Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication","volume":"9","author":"He","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.canlet.2017.05.011_bib308","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/bjc.2013.795","article-title":"Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes","volume":"110","author":"Shapira","year":"2014","journal-title":"Br. J. cancer"},{"key":"10.1016\/j.canlet.2017.05.011_bib309","doi-asserted-by":"crossref","first-page":"3098542","DOI":"10.1155\/2017\/3098542","article-title":"Evaluation of prognostic and predictive significance of circulating MicroRNAs in ovarian cancer patients","volume":"2017","author":"Halvorsen","year":"2017","journal-title":"Dis. Markers"},{"key":"10.1016\/j.canlet.2017.05.011_bib310","doi-asserted-by":"crossref","first-page":"e0164687","DOI":"10.1371\/journal.pone.0164687","article-title":"Prognostic and clinical significance of miRNA-205 in endometrioid endometrial cancer","volume":"11","author":"Wilczynski","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib311","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.3892\/ol.2016.5340","article-title":"MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting beta-catenin","volume":"12","author":"Yang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib312","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1073\/pnas.1305472110","article-title":"A\u00a0microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis","volume":"110","author":"Vecchione","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2017.05.011_bib313","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0004563216649377","article-title":"MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer","volume":"54","author":"Sun","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.canlet.2017.05.011_bib314","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ygyno.2014.04.047","article-title":"MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A","volume":"134","author":"Wang","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib315","doi-asserted-by":"crossref","first-page":"e0141279","DOI":"10.1371\/journal.pone.0141279","article-title":"Carboplatin with decitabine therapy, in recurrent platinum resistant ovarian cancer, alters circulating miRNAs concentrations: a pilot study","volume":"10","author":"Benson","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib316","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.canlet.2017.05.011_bib317","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/2159-8290.CD-13-0159","article-title":"Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment","volume":"3","author":"Nishimura","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2017.05.011_bib318","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1158\/1078-0432.CCR-09-2642","article-title":"Frequent downregulation of miR-34 family in human ovarian cancers","volume":"16","author":"Corney","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib319","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.18632\/oncotarget.7618","article-title":"Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer","volume":"7","author":"Dwivedi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib320","doi-asserted-by":"crossref","first-page":"e86871","DOI":"10.1371\/journal.pone.0086871","article-title":"MiR-26a promotes ovarian cancer proliferation and tumorigenesis","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2017.05.011_bib321","first-page":"1037","article-title":"miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression","volume":"8","author":"Sun","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.canlet.2017.05.011_bib322","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3892\/mmr.2014.2335","article-title":"MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1","volume":"10","author":"Dong","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2017.05.011_bib323","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3892\/ol.2013.1393","article-title":"miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1","volume":"6","author":"Sun","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2017.05.011_bib324","doi-asserted-by":"crossref","first-page":"80633","DOI":"10.18632\/oncotarget.13017","article-title":"MicroRNA-222-3p\/GNAI2\/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival","volume":"7","author":"Fu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib325","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1038\/ncomms6917","article-title":"Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B","volume":"6","author":"Lin","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2017.05.011_bib326","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2011.10.013","article-title":"Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1","volume":"124","author":"Yang","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2017.05.011_bib327","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/onc.2012.575","article-title":"MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine","volume":"33","author":"Xiang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.05.011_bib328","doi-asserted-by":"crossref","first-page":"944","DOI":"10.18632\/oncotarget.1458","article-title":"Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.05.011_bib329","doi-asserted-by":"crossref","first-page":"26457","DOI":"10.18632\/oncotarget.4762","article-title":"MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR\/P70S6K1","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517303336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517303336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T21:27:37Z","timestamp":1569360457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383517303336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":329,"alternative-id":["S0304383517303336"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2017.05.011","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs in gynecological cancers: Small molecules with big implications","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2017.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}